Table E1.
Study | Age, y, mean ± SD | Female sex, % | Hypertension, % | Diabetes, % | Dyslipidemia, % | PVD, % | Stroke/TIA, % | COPD, % | CKD, % | Atrial fibrillation, % | AMI, % | CHF, % | Previous PCI, % | Previous CABG, % | Permanent pacemaker, % |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mangner et al, 20188 | 77.3 ± 5.1 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Jawitz et al, 20209 | N/A | 38 | 87 | 36 | N/A | 32 | 10 | N/A | N/A | 33 | N/A | 76 | 32 | 29 | N/A |
Nakazato et al, 202010 | N/A | 25 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Hirji et al, 202011 | 73.7 ± 8.9 | 35 | 83 | 53 | 72 | 13 | 9 | 35 | 61 | 31 | 7 | 74 | 12 | 24 | N/A |
Tang et al, 202012 | 72.7 ± 10.4 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Fukuhara et al, 202113 | N/A | 36 | 82 | 24 | 77 | N/A | N/A | 12 | 53 | N/A | N/A | N/A | N/A | N/A | 35 |
Brescia et al, 202114 | 72 ± 9 | 33 | 89 | 35 | N/A | 20 | 15 | 50 | 13 | N/A | 37 | N/A | N/A | 14 | 28 |
Fukuhara et al, 202115 | 74 ± 4 | 39 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Malvindi et al, 202116 | 73 ± 7 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 15 | N/A |
Fukuhara et al, 202117 | 73 ± 8.8 | 38 | 90 | 36 | N/A | N/A | 21 | 18 | N/A | N/A | N/A | N/A | N/A | N/A | 16 |
SD, Standard deviation; PVD, peripheral vascular disease; TIA, transient ischemic attack; COPD, chronic obstructive pulmonary disease; CKD, chronic kidney disease; AMI, acute myocardial infarction; CHF, congestive heart failure; PCI, percutaneous coronary intervention; CABG, coronary artery bypass grafting; N/A, not applicable.